Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic partial nephrectomy: 3-year followup.

Alireza Moinzadeh1, Inderbir S Gill, Antonio Finelli

  • 1Section of Laparoscopic and Robotic Surgery, Glickman Urological Institute and Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

The Journal of Urology
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2024
Same author

The use of focal therapy for the treatment of prostate cancer in Canada Where are we, how did we get here, and where are we going?

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2024
Same author

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.

Current oncology (Toronto, Ont.)·2024
Same author

5-α Reductase Inhibitors and Prostate Cancer Mortality.

JAMA network open·2024
Same author

Frequency and clinicopathologic features of renal low-grade oncocytic tumour and eosinophilic vacuolated tumour: reclassification of 605 eosinophilic tumours including patients managed with active surveillance.

Journal of clinical pathology·2024
Same author

2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses.

Societe internationale d'urologie journal : SIUJ·2024
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Laparoscopic partial nephrectomy (LPN) offers comparable oncological outcomes to open surgery for small renal tumors. This study shows no recurrence at 3-year follow-up, supporting LPN as a safe and effective option.

Area of Science:

  • Urology
  • Surgical Oncology
  • Nephrology

Background:

  • Laparoscopic partial nephrectomy (LPN) is an alternative to open partial nephrectomy for small renal tumors.
  • Limited intermediate-term oncological data exist for LPN.

Purpose of the Study:

  • To evaluate the oncological outcomes of LPN in patients with small renal tumors.
  • To assess the safety and efficacy of LPN with a minimum 3-year follow-up.

Main Methods:

  • Retrospective review of 100 patients who underwent LPN with at least 3-year follow-up.
  • Data collected on tumor characteristics, surgical outcomes, and oncological surveillance.
  • Survival data obtained from patient charts and family contact.

Main Results:

Related Experiment Videos

  • All 100 LPNs were completed laparoscopically; mean tumor size was 3.1 cm.
  • No local or port site recurrence observed at a median follow-up of 42 months.
  • Overall survival was 86%, cancer-specific survival was 100%.

Conclusions:

  • LPN provides oncological outcomes comparable to open partial nephrectomy at 3-year follow-up.
  • LPN is a safe and effective treatment for select small renal tumors.